Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study

  1. Willame, C.
  2. Dodd, C.
  3. Durán, C.E.
  4. Elbers, R.J.H.J.
  5. Gini, R.
  6. Bartolini, C.
  7. Paoletti, O.
  8. Wang, L.
  9. Ehrenstein, V.
  10. Kahlert, J.
  11. Haug, U.
  12. Schink, T.
  13. Diez-Domingo, J.
  14. Mira-Iglesias, A.
  15. Carreras, J.J.
  16. Vergara-Hernández, C.
  17. Giaquinto, C.
  18. Barbieri, E.
  19. Stona, L.
  20. Huerta, C.
  21. Martín-Pérez, M.
  22. García-Poza, P.
  23. de Burgos, A.
  24. Martínez-González, M.
  25. Bryant, V.
  26. Villalobos, F.
  27. Pallejà-Millán, M.
  28. Aragón, M.
  29. Souverein, P.
  30. Thurin, N.H.
  31. Weibel, D.
  32. Klungel, O.H.
  33. Sturkenboom, M.C.J.M.
  34. Erakutsi egile guztiak +
Aldizkaria:
Vaccine

ISSN: 1873-2518,  0264-410X

Argitalpen urtea: 2023

Alea: 41

Zenbakia: 1

Orrialdeak: 251-262

Mota: Artikulua

DOI: 10.1016/J.VACCINE.2022.11.031 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus